210 related articles for article (PubMed ID: 22875710)
1. Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233.
Gurley SN; Abidi AH; Allison P; Guan P; Duntsch C; Robertson JH; Kosanke SD; Keir ST; Bigner DD; Elberger AJ; Moore BM
J Neurooncol; 2012 Nov; 110(2):163-77. PubMed ID: 22875710
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids in the treatment of glioblastoma.
Buchalska B; Kamińska K; Owe-Larsson M; Cudnoch-Jędrzejewska A
Pharmacol Rep; 2024 Apr; 76(2):223-234. PubMed ID: 38457018
[TBL] [Abstract][Full Text] [Related]
3. The antitumor action of cannabinoids on glioma tumorigenesis.
Zogopoulos P; Korkolopoulou P; Patsouris E; Theocharis S
Histol Histopathol; 2015 Jun; 30(6):629-45. PubMed ID: 25472761
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.
Sánchez C; de Ceballos ML; Gomez del Pulgar T; Rueda D; Corbacho C; Velasco G; Galve-Roperh I; Huffman JW; Ramón y Cajal S; Guzmán M
Cancer Res; 2001 Aug; 61(15):5784-9. PubMed ID: 11479216
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells.
Echigo R; Sugimoto N; Yachie A; Ohno-Shosaku T
Oncol Rep; 2012 Oct; 28(4):1176-80. PubMed ID: 22842590
[TBL] [Abstract][Full Text] [Related]
6. Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1.
Contassot E; Wilmotte R; Tenan M; Belkouch MC; Schnüriger V; de Tribolet N; Burkhardt K; Dietrich PY
J Neuropathol Exp Neurol; 2004 Sep; 63(9):956-63. PubMed ID: 15453094
[TBL] [Abstract][Full Text] [Related]
7. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
8. Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma.
López-Valero I; Torres S; Salazar-Roa M; García-Taboada E; Hernández-Tiedra S; Guzmán M; Sepúlveda JM; Velasco G; Lorente M
Biochem Pharmacol; 2018 Nov; 157():275-284. PubMed ID: 30125556
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma.
Duntsch C; Divi MK; Jones T; Zhou Q; Krishnamurthy M; Boehm P; Wood G; Sills A; Moore BM
J Neurooncol; 2006 Apr; 77(2):143-52. PubMed ID: 16314952
[TBL] [Abstract][Full Text] [Related]
10. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid signaling in glioma cells.
Ellert-Miklaszewska A; Ciechomska I; Kaminska B
Adv Exp Med Biol; 2013; 986():209-20. PubMed ID: 22879071
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells.
Ciaglia E; Torelli G; Pisanti S; Picardi P; D'Alessandro A; Laezza C; Malfitano AM; Fiore D; Pagano Zottola AC; Proto MC; Catapano G; Gazzerro P; Bifulco M
Oncotarget; 2015 Jun; 6(17):15464-81. PubMed ID: 26008966
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
14. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK
Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptors as novel targets for the treatment of melanoma.
Blázquez C; Carracedo A; Barrado L; Real PJ; Fernández-Luna JL; Velasco G; Malumbres M; Guzmán M
FASEB J; 2006 Dec; 20(14):2633-5. PubMed ID: 17065222
[TBL] [Abstract][Full Text] [Related]
16. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.
McAllister SD; Soroceanu L; Desprez PY
J Neuroimmune Pharmacol; 2015 Jun; 10(2):255-67. PubMed ID: 25916739
[TBL] [Abstract][Full Text] [Related]
17. A Novel Highly Selective Cannabinoid CB2 Agonist Reduces in vitro Growth and TGF-beta Release of Human Glial Cell Tumors.
Cioni C; Tassi M; Marotta G; Mugnaini C; Corelli F; Annunziata P
Cent Nerv Syst Agents Med Chem; 2019; 19(3):206-214. PubMed ID: 31549596
[TBL] [Abstract][Full Text] [Related]
18. Coumarins modulate the anti-glioma properties of temozolomide.
Sumorek-Wiadro J; Zając A; Bądziul D; Langner E; Skalicka-Woźniak K; Maciejczyk A; Wertel I; Rzeski W; Jakubowicz-Gil J
Eur J Pharmacol; 2020 Aug; 881():173207. PubMed ID: 32446712
[TBL] [Abstract][Full Text] [Related]
19. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
[TBL] [Abstract][Full Text] [Related]
20. The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma.
Lu J; Zhuang Z; Song DK; Mehta GU; Ikejiri B; Mushlin H; Park DM; Lonser RR
J Neurosurg; 2010 Aug; 113(2):225-33. PubMed ID: 20001590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
